Skip to Content
Merck
CN

74580

DL-Norleucine

puriss., ≥99.0% (NT)

Synonym(s):

(±)-2-Aminocaproic acid, 2-Aminohexanoic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
CH3(CH2)3CH(NH2)COOH
CAS Number:
Molecular Weight:
131.17
EC Number:
210-462-7
UNSPSC Code:
12352200
PubChem Substance ID:
Beilstein/REAXYS Number:
1721748
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

puriss.

assay

≥99.0% (NT)

mp

>300 °C (lit.)

SMILES string

CCCCC(N)C(O)=O

InChI

1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)

InChI key

LRQKBLKVPFOOQJ-UHFFFAOYSA-N



Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Nabaneeta Mukhopadhyay et al.
Physical chemistry chemical physics : PCCP, 17(6), 4293-4310 (2015-01-13)
Blends of polypropylene (PP) and polyamide 6 (PA6) with multiwalled carbon nanotubes (MWNTs) were prepared using different processing strategies in a twin-screw micro-compounder. The effect of MWNTs on the crystallization behaviour of the PP phase and the PA6 phase of
Kun Shao et al.
Advanced healthcare materials, 4(2), 291-300 (2014-08-16)
Due to complication factors such as blood-brain barrier (BBB), integrating high efficiency of brain target ability with specific cargo releasing into one nanocarrier seems more important. A brain targeting nanoscale system is developed using dehydroascorbic acid (DHA) as targeting moiety.
Sylvie Bannwarth et al.
Brain : a journal of neurology, 137(Pt 8), 2329-2345 (2014-06-18)
Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal